Horizon Therapeutics Public Limited Company EBITDA Margin 2011-2023 | HZNP

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Horizon Therapeutics Public Limited Company (HZNP) over the last 10 years. The current EBITDA margin for Horizon Therapeutics Public Limited Company as of June 30, 2023 is .
EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2023-06-30 $3.64B $0.91B 24.92%
2023-03-31 $3.58B $0.91B 25.51%
2022-12-31 $3.63B $1.07B 29.52%
2022-09-30 $3.70B $1.13B 30.49%
2022-06-30 $3.81B $1.29B 33.95%
2022-03-31 $3.77B $1.28B 34.01%
2021-12-31 $3.23B $0.90B 27.99%
2021-09-30 $2.96B $0.88B 29.83%
2021-06-30 $2.56B $0.75B 29.50%
2021-03-31 $2.19B $0.64B 29.23%
2020-12-31 $2.20B $0.78B 35.55%
2020-09-30 $1.82B $0.59B 32.55%
2020-06-30 $1.52B $0.41B 26.68%
2020-03-31 $1.38B $0.38B 27.47%
2019-12-31 $1.30B $0.39B 29.69%
2019-09-30 $1.29B $0.42B 32.28%
2019-06-30 $1.28B $0.44B 33.93%
2019-03-31 $1.26B $0.42B 33.47%
2018-12-31 $1.21B $0.31B 25.75%
2018-09-30 $1.13B $0.19B 16.52%
2018-06-30 $1.07B $0.11B 9.79%
2018-03-31 $1.06B $-0.08B -7.74%
2017-12-31 $1.06B $-0.06B -5.77%
2017-09-30 $1.09B $-0.07B -6.59%
2017-06-30 $1.03B $-0.09B -8.45%
2017-03-31 $1.00B $0.11B 11.03%
2016-12-31 $0.98B $0.17B 16.92%
2016-09-30 $0.92B $0.24B 26.09%
2016-06-30 $0.93B $0.30B 32.01%
2016-03-31 $0.85B $0.22B 25.41%
2015-12-31 $0.76B $0.21B 28.10%
2015-09-30 $0.62B $0.15B 24.80%
2015-06-30 $0.47B $0.06B 11.83%
2015-03-31 $0.36B $0.05B 14.25%
2014-12-31 $0.30B $0.04B 11.78%
2014-09-30 $0.22B $0.01B 2.69%
2014-06-30 $0.17B $0.01B 5.23%
2014-03-31 $0.12B $-0.01B -4.27%
2013-12-31 $0.07B $-0.03B -40.54%
2013-09-30 $0.05B $-0.05B -92.00%
2013-06-30 $0.03B $-0.06B -190.91%
2013-03-31 $0.03B $-0.07B -257.69%
2012-12-31 $0.02B $-0.07B -350.00%
2012-09-30 $0.02B $-0.07B -383.33%
2012-06-30 $0.01B $-0.07B -609.09%
2012-03-31 $0.01B $-0.06B -725.00%
2011-12-31 $0.01B $-0.05B -642.86%
2011-09-30 $0.00B $-0.04B -975.00%
2011-06-30 $0.01B $-0.04B -600.00%